Document is current
Any future updates will be listed below
-
Authors
Sroubek, Jakub https://orcid.org/0000-0003-2490-5106
Bhargava, Mandeep
Higuchi, Koji
Hussein, Ayman A.
Varma, Niraj
Wazni, Oussama M.
Anter, Elad
-
Funding
Funding for this research was provided by:
Biosense Webster (IIS-564)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 28 April 2026
First Online: 6 May 2026
Declarations
:
: This study has been approved by the Cleveland Clinic Institutional Review Board. All study subjects provided written informed consent.
: NCT04477499 (clinicaltrials.gov database).
: Dr. Sroubek has received speaking fees from Biosense Webster and Abbott and receives research grant support from Abbott. Dr. Higuchi has served as a consultant for Abbott. Dr. Hussein receives research grant support from Boston Scientific. Dr. Varma has served as a consultant for Abbott, Biotronik, Boston Scientific and Medtronic. Dr. Wazni has served as a consultant for Abbott, Biosense Webster, Boston Scientific and Medtronic. Dr. Anter is a consultant to and has received equity from Affera-Medtronic. He serves in consulting and advisory capacities for Biosense Webster, Boston Scientific, and Abbott Medical. He receives research grants from Biosense Webster and Medtronic. Dr. Bhargava has reported that he has no relationships relevant to the contents of this paper to disclose.
